Guidance

In vitro diagnostic point-of-care test devices

Advice and guidance on the management and use of point-of-care testing (POCT) in vitro diagnostic (IVD) devices.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 22 July 2005
• Last updated: 3 February 2021 — See all updates

Documents

In vitro diagnostic point-of-care test devices

PDF, 221 KB, 22 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Management and use of IVD point of care test devices

HTML

Details

This Medicines and Healthcare Products Regulatory Agency (MHRA) guidance is for people involved in the management and use of POCT services in primary and secondary care including:

• managerial staff
• scientific staff
• technical
• clinical and nursing staff

While many of the issues are relevant to the performance of POCT in a hospital environment, the principles also apply to their use in:

• outpatient clinics
• community care
• GP practices
• community providers
• primary care settings

Published 22 July 2005
Last updated 3 February 2021 + show all updates

1. 3 February 2021

   Published a new version of the guidance following the end of the transition period. The guidance has now also been published in HTML format.

2. 22 July 2005

   First published.